SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-020124
Filing Date
2022-04-15
Accepted
2022-04-15 16:06:41
Documents
1
Period of Report
2022-04-05

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 8793
  Complete submission text file 0001213900-22-020124.txt   10143
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Issuer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address
Bodenstedt Matthias (Reporting) CIK: 0001920545 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39630 | Film No.: 22830113